FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387610123> ?p ?o ?g. }

• W4387610123 abstract "Current treatment of acute leukemia is based on anthracycline chemotherapy. Anthracyclines, despite improving patient survival, have serious cardiotoxicity and therefore cardiac monitoring should be a priority. The purpose of this study is to explore the possible early predictors of anthracycline-induced subclinical cardiotoxicity(AISC)in acute leukemia patients.We conducted a prospective observational study involving 51 patients with acute leukemia treated with anthracycline. Demographic data, clinical variables, echocardiography variables and biochemical variables were collected at baseline and after 3 cycles of chemotherapy. Patients were divided into the AISC and No-AISC groups according to changes of global longitudinal peak systolic strain. Regression models and receiver operating characteristic curve analysis were used to explore the relationship between the variables and AISC.17 of the patients suffered subclinical cardiotoxicity after 3 cycles of anthracycline treatment. Multiple logistic regression analysis showed a significant association of DBil (OR 0.612, 95% CI 0.409-0.916, p = 0.017), TBil (OR 0.841, 95% CI 0.717-0.986, p = 0.033), PLT (OR 1.012, 95% CI 1.002-1.021, p = 0.016) and Glu (OR 1.873, 95% CI 1.009-3.475, p = 0.047) with the development of AISC. After 3 cycles of chemotherapy, there was a significant difference in PLT between the AISC and NO-AISC groups. Moreover, the dynamic changes in PLT from baseline to after 3 cycles of chemotherapy were each statistically significant in the AISC and NO-AISC groups. The combination of PLT and N-terminal pro-B-type natriuretic peptide (NT-proBNP) had the highest area under curves (AUC) for the diagnosis of AISC than PLT and NT-proBNP alone (AUC = 0.713, 95%CI: 0.56-0.87, P = 0.017).Total bilirubin (TBil), direct bilirubin (DBil), platelets (PLT) and blood glucose (Glu) are independent influencing factors for AISC in acute leukemia patients receiving anthracycline therapy. Bilirubin may be a protective factor and PLT may be a contributing factor for AISC. The combination of baseline PLT and baseline NT-proBNP shows satisfactory predictive ability for AISC in acute leukemia cases treated with 3 cycles of chemotherapy." @default.
• W4387610123 created "2023-10-14" @default.
• W4387610123 creator A5008650962 @default.
• W4387610123 creator A5009318195 @default.
• W4387610123 creator A5018049399 @default.
• W4387610123 creator A5039230721 @default.
• W4387610123 creator A5049982592 @default.
• W4387610123 creator A5059688702 @default.
• W4387610123 creator A5087144373 @default.
• W4387610123 date "2023-10-13" @default.
• W4387610123 modified "2023-10-15" @default.
• W4387610123 title "Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients" @default.
• W4387610123 cites W1490606256 @default.
• W4387610123 cites W1862027433 @default.
• W4387610123 cites W1987593270 @default.
• W4387610123 cites W2016236015 @default.
• W4387610123 cites W2020940689 @default.
• W4387610123 cites W2028362773 @default.
• W4387610123 cites W2042122319 @default.
• W4387610123 cites W2044437167 @default.
• W4387610123 cites W2047137672 @default.
• W4387610123 cites W2057051793 @default.
• W4387610123 cites W2064375180 @default.
• W4387610123 cites W2083733554 @default.
• W4387610123 cites W2085163888 @default.
• W4387610123 cites W2090670453 @default.
• W4387610123 cites W2092000328 @default.
• W4387610123 cites W2106926141 @default.
• W4387610123 cites W2115686938 @default.
• W4387610123 cites W2140182328 @default.
• W4387610123 cites W2145050940 @default.
• W4387610123 cites W2148489323 @default.
• W4387610123 cites W2162689981 @default.
• W4387610123 cites W2164159671 @default.
• W4387610123 cites W2170928666 @default.
• W4387610123 cites W2298142163 @default.
• W4387610123 cites W2334701002 @default.
• W4387610123 cites W2340420693 @default.
• W4387610123 cites W2411806810 @default.
• W4387610123 cites W2468397770 @default.
• W4387610123 cites W2730846812 @default.
• W4387610123 cites W2753385863 @default.
• W4387610123 cites W2995471120 @default.
• W4387610123 cites W3041303370 @default.
• W4387610123 cites W3204395813 @default.
• W4387610123 cites W4224444580 @default.
• W4387610123 doi "https://doi.org/10.1186/s12885-023-11060-5" @default.
• W4387610123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37833648" @default.
• W4387610123 hasPublicationYear "2023" @default.
• W4387610123 type Work @default.
• W4387610123 citedByCount "0" @default.
• W4387610123 crossrefType "journal-article" @default.
• W4387610123 hasAuthorship W4387610123A5008650962 @default.
• W4387610123 hasAuthorship W4387610123A5009318195 @default.
• W4387610123 hasAuthorship W4387610123A5018049399 @default.
• W4387610123 hasAuthorship W4387610123A5039230721 @default.
• W4387610123 hasAuthorship W4387610123A5049982592 @default.
• W4387610123 hasAuthorship W4387610123A5059688702 @default.
• W4387610123 hasAuthorship W4387610123A5087144373 @default.
• W4387610123 hasBestOaLocation W43876101231 @default.
• W4387610123 hasConcept C113280763 @default.
• W4387610123 hasConcept C121608353 @default.
• W4387610123 hasConcept C126322002 @default.
• W4387610123 hasConcept C151956035 @default.
• W4387610123 hasConcept C164705383 @default.
• W4387610123 hasConcept C2776694085 @default.
• W4387610123 hasConcept C2776802502 @default.
• W4387610123 hasConcept C2776863199 @default.
• W4387610123 hasConcept C2778233292 @default.
• W4387610123 hasConcept C2778461978 @default.
• W4387610123 hasConcept C530470458 @default.
• W4387610123 hasConcept C71924100 @default.
• W4387610123 hasConcept C90924648 @default.
• W4387610123 hasConceptScore W4387610123C113280763 @default.
• W4387610123 hasConceptScore W4387610123C121608353 @default.
• W4387610123 hasConceptScore W4387610123C126322002 @default.
• W4387610123 hasConceptScore W4387610123C151956035 @default.
• W4387610123 hasConceptScore W4387610123C164705383 @default.
• W4387610123 hasConceptScore W4387610123C2776694085 @default.
• W4387610123 hasConceptScore W4387610123C2776802502 @default.
• W4387610123 hasConceptScore W4387610123C2776863199 @default.
• W4387610123 hasConceptScore W4387610123C2778233292 @default.
• W4387610123 hasConceptScore W4387610123C2778461978 @default.
• W4387610123 hasConceptScore W4387610123C530470458 @default.
• W4387610123 hasConceptScore W4387610123C71924100 @default.
• W4387610123 hasConceptScore W4387610123C90924648 @default.
• W4387610123 hasIssue "1" @default.
• W4387610123 hasLocation W43876101231 @default.
• W4387610123 hasLocation W43876101232 @default.
• W4387610123 hasOpenAccess W4387610123 @default.
• W4387610123 hasPrimaryLocation W43876101231 @default.
• W4387610123 hasRelatedWork W1981259913 @default.
• W4387610123 hasRelatedWork W1992099483 @default.
• W4387610123 hasRelatedWork W2053291556 @default.
• W4387610123 hasRelatedWork W2396926985 @default.
• W4387610123 hasRelatedWork W2420051576 @default.
• W4387610123 hasRelatedWork W2569855433 @default.
• W4387610123 hasRelatedWork W2730846812 @default.
• W4387610123 hasRelatedWork W4323066430 @default.
• W4387610123 hasRelatedWork W95894433 @default.

• next